Company Profile >>

December 28, 2011 with a registered capital of 15,873,000 yuan, covers an area of 23,000 square meters, construction began in May 2012, September put into use. Company's existing R & D center has been built using the 1000 meters, according to the construction of the new GMP standard production workshop and Peptide Drugs central laboratory 1700 meters, the existing including lyophilizer, high performance liquid chromatography, solid phase synthesis instrument, such as production, testing , public works equipment 110 sets. Our main business is the development of biotechnology, is committed peptide drug development and production, in the research of the nine peptide production processes mature, low cost, a leading domestic level, but are more indications of sustained high growth markets major